EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Quality control and non-clinical testing of iPSC- and ESC-derived medicinal products: A systematic review

Akvilė Gasiūnaitė, Mara Tihaya, Inge van Amerongen-Westra, Fong Lin, Pema Gurung, Bahareh Rajaei, Eelco de Koning, Françoise Carlotti, Pauline Meij

Stem Cell Reports · 2026

DOI: 10.1016/j.stemcr.2026.103084 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Akvilė Gasiūnaitė und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell and Gene Therapy, Leiden University Medical Center, Leiden, the Netherlands; Department of Internal Medicine, Leiden University Medic…. Hauptthemen laut MEDLINE: Embryonic Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leids Universitair Medisch Centrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of specific resources for quality control (QC) and non-clinical testing of cell-based medicinal products derived from embryonic and induced pluripotent stem cells (PSCs) contributes to uncertainty, variability, and delay in devising testing strategies. We conducted a systematic review on testing practices for diverse PSC-derived medicinal products using a custom-made ranking system, compiling a comprehensive "QC menu" of relevant critical quality attributes, established fit-for-purpose and promising techniques, and study designs for product development or clinical release. This consolidated resource could benefit product developers and regulators by creating informative testing strategies, ultimately increasing harmonization, facilitating clinical translation, and ensuring patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryonic Stem CellsInduced Pluripotent Stem CellsAnimalsHumansQuality ControlRegenerative Medicine

Stichwörter der Autor:innen

cell therapycharacterizationembryonic stem cellsinduced pluripotent stem cellsnon-clinical testingquality controlregenerative medicinerelease testingsafety and efficacysystematic review

Autor:innen und Institutionen

  • Center for Cell and Gene Therapy, Leiden University Medical Center, Leiden, the Netherlands; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Center for Cell and Gene Therapy, Leiden University Medical Center, Leiden, the Netherlands.
  • Walaeus Library, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
  • Center for Cell and Gene Therapy, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: p.meij@lumc.nl.

Förderung

  • Leids Universitair Medisch Centrum

Zitieren

APA

Gasiūnaitė, A., Tihaya, M., van Amerongen-Westra, I., Lin, F., Gurung, P., Rajaei, B., de Koning, E., Carlotti, F., & Meij, P. (2026). Quality control and non-clinical testing of iPSC- and ESC-derived medicinal products: A systematic review. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.103084

Vancouver

Gasiūnaitė A, Tihaya M, van Amerongen-Westra I, Lin F, Gurung P, Rajaei B, et al. Quality control and non-clinical testing of iPSC- and ESC-derived medicinal products: A systematic review. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.103084

BibTeX
@article{Gasinait2026,
  author = {Gasiūnaitė, Akvilė and Tihaya, Mara and van Amerongen-Westra, Inge and Lin, Fong and Gurung, Pema and Rajaei, Bahareh and de Koning, Eelco and Carlotti, Françoise and Meij, Pauline},
  title = {Quality control and non-clinical testing of iPSC- and ESC-derived medicinal products: A systematic review},
  journal = {Stem Cell Reports},
  year = {2026},
  doi = {10.1016/j.stemcr.2026.103084}
}
Kostenlos starten →